🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for GVHD - Graft-Versus-Host Disease

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD) NCT06247150NA1 site📍 Pessac University Hospital, Bordeaux · Tests: Additional blood sample, cGVHD target tissue biopsy Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant NCT06996119Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Busulfan, Computed Tomography, Cyclophosphamide, Echocardiography Test Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease NCT06910969NA2 sites📍 Miami📍 Boston Massachusetts General Hospital · Tests: HORIZONS Intervention, Minimally enhanced usual care Dapagliflozin in Allo-HCT for aGVHD NCT06626737Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Dapagliflozin (DAPA) Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor NCT07238712Phase 21 site📍 Saint Petersburg St. Petersburg State Pavlov Medical University · Tests: Ruxolitinib, Abatacept (Orencia) Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD) NCT07776210Phase 35 sites📍 Beverly Hills📍 Beverly Hills📍 Palm Harbor Regenerative Ocular Immunobiologics LLC · Tests: d-MAPPS™ Ophthalmic Solution, Matching vehicle control Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation NCT06008808Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Ruxolitinib, Abatacept Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population NCT06995521Phase 21 site📍 Ann Arbor Sung Won Choi · Tests: Vorinostat Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation NCT06649201n/a1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Vulvovaginal Symptom Questionnaire, Vaginal Microbiome Evaluation Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease NCT04744116EARLY Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Cellular Therapy, Ruxolitinib Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD NCT07364617Phase 21 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Fecal microbiota transplantation (FMT) Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) NCT07509749Phase 21 site📍 Beijing Daihong Liu · Tests: Ruxolitinib and Methylprednisolone, Methylprednisolone The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation NCT05436418Phase 1, Phase 22 sites📍 Duarte📍 Bethesda National Cancer Institute (NCI) · Tests: Melphalan, Sirolimus, Total Body Irradiation (TBI), Cyclophosphamide, Mycophenolate Mofeti Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies NCT05327023Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: donor lymphocyte infusion, Cyclophosphamide, Busulfan, Mycophenolate mofetil, Fludarabine Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment NCT06904599Phase 21 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Human chorionic gonadotropin (hCG), Prednisone, Dexamethasone A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) NCT06619561Phase 226 sites📍 Duarte📍 Los Angeles📍 Orange Deciphera Pharmaceuticals, LLC · Tests: Vimseltinib Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD NCT02918188Phase 21 site📍 Beijing Navy General Hospital, Beijing · Tests: Hydrogen The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients NCT04700657n/a1 site📍 Indianapolis Indiana University · Tests: corneal sensation test Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation NCT07025538Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Best Practice, Biomarker Analysis, Biospecimen Collection, Questionnaire Administration, Ruxolitinib A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations NCT07325253Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: [18F]-4FN, PET-CT Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) NCT05289167Phase 1, Phase 21 site📍 New Hyde Park Northwell Health · Tests: Cyclophosphamide, Abatacept, Bortezomib Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model NCT06880419Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Recombinant Humanized Anti-CD25 Monoclonal Antibody Injection GMPA Versus PPI for Gastric Protection and aGVHD Risk NCT07791849NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Teprenone, Esomeprazole Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD NCT05921305Phase 32 sites📍 Beijing📍 Guangzhou Peking University People's Hospital · Tests: MTX, Corticosteroid Evaluation of Patients With Immune Function Abnormalities NCT00128973n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523n/a1 site📍 Xining Yigeng Cao,MD,PhD Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) NCT03970096Phase 23 sites📍 Tampa📍 Pittsburgh📍 Seattle Fred Hutchinson Cancer Center · Tests: Total-Body Irradiation, Thiotepa, Fludarabine, Tacrolimus, Allogeneic CD34+-enriched and CD45RA-depleted PBSCs Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives NCT00001529n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: G-CSF Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia NCT06392711Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: Mesenchymal Stromal Cells (MSC) Dose Level 0, Mesenchymal Stromal Cells (MSC) Dose Level 1 Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain NCT07002944NA1 site📍 Cairo Cairo University · Tests: Brachial plexus pulsed radiofrequency, Sholder individual nerves pulsed radiofrequency, Control
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy